Targeting neurotransmitter-mediated inflammatory mechanisms of psychiatric drugs to mitigate the double burden of multimorbidity and polypharmacy

The increased incidence of multimorbidities and polypharmacy is a major concern, particularly in the growing aging population. While polypharmacy can be beneficial, in many cases it can be more harmful than no treatment, especially in individuals suffering from psychiatric disorders, who have elevat...

Descripción completa

Detalles Bibliográficos
Autor principal: Matt, Stephanie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles from the Special Issue on Emerging PNI research: future leaders in focus; Edited by Amanda Kentner, Lois Harden, Denis de Melo Soares and Christoph Rummel
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495104/
https://www.ncbi.nlm.nih.gov/pubmed/34647105
http://dx.doi.org/10.1016/j.bbih.2021.100353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495104/
https://www.ncbi.nlm.nih.gov/pubmed/34647105
http://dx.doi.org/10.1016/j.bbih.2021.100353

Ejemplares similares